SHINPOONG PHARMACEUTICAL CO.,LTD (신풍제약(주))
KOSPI Stock Code: 019170 | DART Corp Code: 00137359
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | SHINPOONG PHARMACEUTICAL CO.,LTD |
|---|---|
| Korean legal name | 신풍제약(주) |
| Alternate names | 신풍제약 |
| Market | KOSPI |
| Stock Code | 019170 |
| DART Corp Code | 00137359 |
| CEO | 유 제 만 |
| Business Registration No. | 1348103819 |
| Corporate Registration No. | 1301110011815 |
| Established Date | 1986-07-23 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 경기도 안산시 단원구 원시로 7 |
| Homepage | https://www.shinpoong.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320000611 |
| verified_at | 2026-11-01T02:18:48.871Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320000611
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 234,680,653,227 | KRW 221,094,069,689 |
| Operating Income (영업이익) | KRW 14,255,167,972 | KRW -20,455,432,597 |
| Net Income (당기순이익) | KRW 8,389,168,304 | KRW -15,373,463,449 |
| Total Assets (자산총계) | KRW 352,466,324,389 | KRW 342,092,805,074 |
| Total Liabilities (부채총계) | KRW 81,738,685,157 | KRW 84,002,936,786 |
| Total Equity (자본총계) | KRW 270,727,639,232 | KRW 258,089,868,288 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-22 | 20261022800250 | Material Business Matters Related to Investment Decisions (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인) | 투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인) | 신풍제약 |
2026-09-15 | 20260915800457 | Material Business Matters Related to Investment Decisions (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인 신청) | 투자판단관련주요경영사항 (급성 허혈성 뇌졸중 치료제 SP8203 임상 3상 시험변경계획 승인 신청) | 신풍제약 |
2026-08-14 | 20260814003040 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 신풍제약 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320000611 | verified_at: 2026-11-01T02:18:48.871Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.